This Week at FDA: Califf considering diagnostic reform rulemaking, Ashley says goodbye

This Week at FDAThis Week at FDAAPIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsEuropeMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/Policy